Strata Skin Sciences Q1 2024 GAAP EPS $(0.10) Misses $(0.07) Estimate, Sales $6.754M Miss $6.912M Estimate
Portfolio Pulse from Benzinga Newsdesk
Strata Skin Sciences (NASDAQ:SSKN) reported Q1 2024 GAAP EPS of $(0.10), missing the $(0.07) estimate by 42.86%. Sales were $6.754M, missing the $6.912M estimate by 2.28%. Both EPS and sales showed declines compared to the same period last year.
May 15, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Strata Skin Sciences reported Q1 2024 GAAP EPS of $(0.10), missing the $(0.07) estimate by 42.86%. Sales were $6.754M, missing the $6.912M estimate by 2.28%. Both EPS and sales showed declines compared to the same period last year.
The significant miss on both EPS and sales estimates, along with year-over-year declines, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100